Erkang Pharmaceuticals: Controlling shareholder Shuai Fangwen has reduced holdings by 0.52%

Erkang Pharmaceuticals announced that the deadline for the reduction plan by its controlling shareholder, Shuaifang Wen, has expired. From April 23, 2026 to July 22, 2026, Shuaifang Wen reduced his holdings by 10,776,000 shares through centralized bidding, accounting for 0.52% of the total share capital, with an average reduction price of 4.38 yuan per share. After this reduction, Shuaifang Wen holds 843 million shares, accounting for 40.86% of the total share capital.